Try our Advanced Search for more refined results
June 19, 2014
Allos Therapeutics Inc. et al v. Fresenius Kabi USA, LLC
Case Number:
1:14-cv-00778
Court:
Nature of Suit:
Judge:
Firms
Companies
- Fresenius Kabi AG
- Memorial Sloan Kettering Cancer Center
- Southern Research Institute Inc.
- Spectrum Pharmaceuticals Inc.
- SRI International Inc.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
July 13, 2016
Spectrum Settles Cancer Drug Patent Row With Fresenius
Spectrum Pharmaceuticals said Wednesday that it had reached a settlement with Fresenius Kabi in a Delaware federal suit accusing it of infringing three patents for its cancer drug Folotyn, after reaching other deals with Teva Pharmaceuticals, Dr. Reddy's and Sandoz.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login